Jared Kaltwasser - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Jared Kaltwasser's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Jared Kaltwasser
Verified
Healthcare and Business Writer, Freelance
Iowa
Beats
Business and Finance
Music!
Content
By Jared Kaltwasser Verified| American Journal of Managed Care Verified Patients with chronic lymphocytic leukemia (CLL) who are taking Bruton tyrosine kinase (BTK) inhibitors do not need to pause their medications when getting vaccinated against coronavirus disease 2019 (COVID-19), a new report has found.1Previous research had suggested that taking a 3-week pause from BTK inhibitors would improve SARS-CoV-2 antibody responses to vaccination, but the new report indicates that such a pause provides no significant benefit.
By Jared Kaltwasser Verified| Managed Healthcare Executive Verified Magnetic resonance imaging (MRI) appears to be able to meaningfully track functional changes in Duchenne muscular dystrophy (DMD), according to a recent analysis. If validated in additional studies, MRI-based biomarkers could become a surrogate endpoint in future trials involving patients with DMD, the study suggests. The findings were published in Muscle & Nerve. The study was sponsored by Pfizer Inc. and AMRA Medical. Lead author Sarah P.
By Jared Kaltwasser Verified| Managed Healthcare Executive Verified A new meta-analysis of longitudinal studies supports the use of corticosteroids as a means to preserve motor and respiratory function in patients with Duchenne muscular dystrophy (DMD). The analysis, however, found the benefits are less clear in terms of cardiac outcomes. The findings were presented in an abstract at the Muscular Dystrophy Association’s 2025 Clinical and Scientific Conference, held last month in Dallas. Lead author Mahmoud M.
Company Info
Freelance
Freelancer.com is the largest freelancing and crowdsourcing marketplace in the world, connecting over 81 million employers and freelancers across more than 247 countries. Founded in 2009 and based in Sydney, Australia, the platform allows employers to post jobs while freelancers can bid on these projects. It is publicly traded on the Australian Securities Exchange under the ticker ASX:FLN. The platform supports a variety of work categories, including software development, writing, design, and marketing. Freelancer.com also offers contests for creative work, where employers can award prize money to winning entries. Users can choose from different membership plans, including free and paid subscriptions, which provide various benefits. The mobile app enhances project management and communication for users on the go. With a diverse customer base that includes individuals, small businesses, and large enterprises, Freelancer.com plays a significant role in the global online economy.
De Pere, Wisconsin, United States